<VariationArchive VariationID="4414" VariationName="NM_020919.4(ALS2):c.553del (p.Thr185fs)" VariationType="Deletion" Accession="VCV000004414" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2013-10-01" MostRecentSubmission="2020-02-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19453" VariationID="4414">
      <GeneList>
        <Gene Symbol="ALS2" FullName="alsin Rho guanine nucleotide exchange factor ALS2" GeneID="57679" HGNC_ID="HGNC:443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201700267" stop="201780933" display_start="201700267" display_stop="201780933" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202564985" stop="202645894" display_start="202564985" display_stop="202645894" Strand="-" />
          </Location>
          <OMIM>606352</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020919.4(ALS2):c.553del (p.Thr185fs)</Name>
      <CanonicalSPDI>NC_000002.12:201761440:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201761441" stop="201761441" display_start="201761441" display_stop="201761441" variantLength="1" positionVCF="201761440" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202626164" stop="202626164" display_start="202626164" display_stop="202626164" variantLength="1" positionVCF="202626163" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>c.553delA</Name>
      </OtherNameList>
      <ProteinChange>T185fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.202626164del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.202626164del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.201761441del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.201761441del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008775.1" sequenceAccession="NG_008775" sequenceVersion="1" change="g.24732del">
            <Expression>NG_008775.1:g.24732del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001135745.2" sequenceAccession="NM_001135745" sequenceVersion="2" change="c.553del">
            <Expression>NM_001135745.2:c.553del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001129217.1" sequenceAccession="NP_001129217" sequenceVersion="1" change="p.Thr185fs">
            <Expression>NP_001129217.1:p.Thr185fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020919.4" sequenceAccession="NM_020919" sequenceVersion="4" change="c.553del" MANESelect="true">
            <Expression>NM_020919.4:c.553del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065970.2" sequenceAccession="NP_065970" sequenceVersion="2" change="p.Thr185fs">
            <Expression>NP_065970.2:p.Thr185fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_654" sequenceAccession="LRG_654">
            <Expression>LRG_654:g.24732del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_654t1" sequenceAccession="LRG_654t1">
            <Expression>LRG_654t1:c.553del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_654p1" sequenceAccession="LRG_654p1" change="p.Thr185fs">
            <Expression>LRG_654p1:p.Thr185fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340250" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606352.0011" DB="OMIM" />
        <XRef Type="rs" ID="386134174" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020919.4(ALS2):c.553del (p.Thr185fs) AND Amyotrophic lateral sclerosis type 2, juvenile" Accession="RCV000004664" Version="17">
        <ClassifiedConditionList TraitSetID="1212">
          <ClassifiedCondition DB="MedGen" ID="C1859807">Amyotrophic lateral sclerosis type 2, juvenile</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-02-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020919.4(ALS2):c.553del (p.Thr185fs) AND Juvenile primary lateral sclerosis" Accession="RCV000995489" Version="13">
        <ClassifiedConditionList TraitSetID="1213">
          <ClassifiedCondition DB="MedGen" ID="C1853396">Juvenile primary lateral sclerosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-01-16" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-10-01" MostRecentSubmission="2020-02-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16240357</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301421</ID>
          <ID Source="BookShelf">NBK1243</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1212" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="297" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Amyotrophic lateral sclerosis type 2, juvenile</ElementValue>
                <XRef ID="MONDO:0008780" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amyotrophic lateral sclerosis type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALS, JUVENILE</ElementValue>
                <XRef Type="MIM" ID="205100" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ALS2</ElementValue>
                <XRef Type="MIM" ID="205100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ALSJ</ElementValue>
                <XRef Type="MIM" ID="205100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ALS2-related disorder involves retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprises a clinical continuum of the following three phenotypes: Infantile ascending hereditary spastic paraplegia (IAHSP), characterized by onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life, progressive weakness and spasticity of the upper limbs by age seven to eight years, and wheelchair dependence in the second decade with progression toward severe spastic tetraparesis and a pseudobulbar syndrome caused by progressive cranial nerve involvement. Juvenile primary lateral sclerosis (JPLS), characterized by upper motor neuron findings of pseudobulbar palsy and spastic quadriplegia without dementia or cerebellar, extrapyramidal, or sensory signs. Juvenile amyotrophic lateral sclerosis (JALS or ALS2), characterized by onset between ages three and 20 years. All affected individuals show a spastic pseudobulbar syndrome (spasticity of speech and swallowing) together with spastic paraplegia. Some individuals are bedridden by age 12 to 50 years.</Attribute>
                <XRef ID="NBK1243" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15137" />
                <XRef ID="15137" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9470" />
                <XRef ID="9470" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301421</ID>
                <ID Source="BookShelf">NBK1243</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301623</ID>
                <ID Source="BookShelf">NBK1450</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf</URL>
                <CitationText>Orphanet, Amyotrophic lateral sclerosis, 2007</CitationText>
              </Citation>
              <XRef ID="300605" DB="Orphanet" />
              <XRef ID="C1859807" DB="MedGen" />
              <XRef ID="MONDO:0008780" DB="MONDO" />
              <XRef Type="MIM" ID="205100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1213" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3382" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PLS juvenile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Juvenile primary lateral sclerosis</ElementValue>
                <XRef ID="Primary+lateral+sclerosis+juvenile/5952" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011663" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JPLS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PLSJ</ElementValue>
                <XRef Type="MIM" ID="606353" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ALS2-related disorder involves retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprises a clinical continuum of the following three phenotypes: Infantile ascending hereditary spastic paraplegia (IAHSP), characterized by onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life, progressive weakness and spasticity of the upper limbs by age seven to eight years, and wheelchair dependence in the second decade with progression toward severe spastic tetraparesis and a pseudobulbar syndrome caused by progressive cranial nerve involvement. Juvenile primary lateral sclerosis (JPLS), characterized by upper motor neuron findings of pseudobulbar palsy and spastic quadriplegia without dementia or cerebellar, extrapyramidal, or sensory signs. Juvenile amyotrophic lateral sclerosis (JALS or ALS2), characterized by onset between ages three and 20 years. All affected individuals show a spastic pseudobulbar syndrome (spasticity of speech and swallowing) together with spastic paraplegia. Some individuals are bedridden by age 12 to 50 years.</Attribute>
                <XRef ID="NBK1243" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4485" />
                <XRef ID="4485" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301421</ID>
                <ID Source="BookShelf">NBK1243</ID>
              </Citation>
              <XRef ID="247604" DB="Orphanet" />
              <XRef ID="C1853396" DB="MedGen" />
              <XRef ID="MONDO:0011663" DB="MONDO" />
              <XRef Type="MIM" ID="606353" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24838" SubmissionDate="2020-02-21" DateLastUpdated="2020-02-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606352.0011_AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE" title="ALS2, 1-BP DEL, 553A_AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE" />
        <ClinVarAccession Accession="SCV000024838" DateUpdated="2020-02-24" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Turkish man, born of consanguineous parents, with juvenile amyotrophic lateral sclerosis-2 (ALS2; 205100), Kress et al. (2005) identified a homozygous 1-bp deletion (553delA) in exon 4 of the ALS2 gene, resulting in a frameshift and premature termination of the protein at residue 189. The mutation affects both the long and short forms of the protein. The patient had a severe disease course; onset occurred at age 2 years and he was wheelchair-bound by age 16. The patient's unaffected parents and 2 unaffected brothers were heterozygous for the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">16240357</ID>
              </Citation>
              <XRef DB="OMIM" ID="205100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALS2" />
          </GeneList>
          <Name>ALS2, 1-BP DEL, 553A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 553A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606352.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="99690" SubmissionDate="2013-04-30" DateLastUpdated="2013-10-01" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="c.553delA_NBK1243" title="c.553delA and ALS2-Related Disorders" />
        <ClinVarAccession Accession="SCV000058638" DateUpdated="2013-10-01" DateCreated="2013-05-03" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-02-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="nucleotide change">c.553delA</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALS2-Related Disorders</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1243" />
            <XRef DB="OMIM" ID="205100" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2267884" SubmissionDate="2020-01-21" DateLastUpdated="2020-02-03" DateCreated="2020-02-03">
        <ClinVarSubmissionID localKey="40-20200121" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001149677" DateUpdated="2020-02-03" DateCreated="2020-02-03" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU MÃ¼nchen" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <FamilyData PedigreeID="94-20200121" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">94-20200121</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="G" referenceAllele="GT" start="202626163" stop="202626164" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606353" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6902622</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2267884" TraitType="Disease" MappingType="XRef" MappingValue="606353" MappingRef="OMIM">
        <MedGen CUI="C1853396" Name="Juvenile primary lateral sclerosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="99690" TraitType="Disease" MappingType="Name" MappingValue="ALS2-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN169291" Name="ALS2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24838" TraitType="Disease" MappingType="Name" MappingValue="AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE" MappingRef="Preferred">
        <MedGen CUI="C1859807" Name="Amyotrophic lateral sclerosis type 2, juvenile" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

